Abbott LaboratoriesABTNYSE
Loading
Cash Flow PerformanceFair Value
Percentile Rank36
3Y CAGR-5.9%
5Y CAGR+2.8%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-5.9%/yr
vs +1.2%/yr prior
5Y CAGR
+2.8%/yr
Recent deceleration
Acceleration
-7.1pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.38% | +4.2% |
| 2024 | 3.24% | +22.3% |
| 2023 | 2.65% | -34.6% |
| 2022 | 4.05% | +17.1% |
| 2021 | 3.46% | +17.4% |
| 2020 | 2.95% | +0.7% |
| 2019 | 2.93% | -24.2% |
| 2018 | 3.86% | -13.3% |
| 2017 | 4.46% | +21.1% |
| 2016 | 3.68% | - |